Internal Medicine · New York, NY
NPI
1356434104
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
98 E Broadway, Lower Level
New York, NY, 10002
Phone (212) 343-9261
Medicare paid, 2024
$8,919
171 services
Medicare patients, 2024
23
Average age 70
Drug cost, 2024
$2.4M
14,974 prescriptions
Company payments, 2025
$3,231
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bo Chen was code 99213 (office e&m - established), 44 times for 19 patients. In total Bo Chen billed 171 services in 19 codes, and Medicare paid $8,919.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 44 | 19 | $60.39 | $2,657 |
| 36415 Venipuncture Blood Collection | Office | 26 | 17 | $8.65 | $225 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 11 | 11 | $21.19 | $233 |
By year: 2022 $10K for 228 services; 2023 $10K for 223 services; 2024 $8,919 for 171 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 26 | 17 | $8.65 | $225 |
Medicare prescription drug claims, 2024
In 2024, the drug Bo Chen prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,074 prescriptions and refills. In total Bo Chen wrote 14,974 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,074 | 2,143 | 243 | $9,037 |
| Losartan Potassium Generic | 954 | 2,012 | 206 | $7,324 |
| Vascepa Icosapent Ethyl | 598 | 940 | 121 | $327K |
| Raloxifene Hcl Generic | 590 | 1,091 | 109 | $11K |
| Simvastatin Generic | 524 | 1,100 | 117 | $3,675 |
| Amlodipine Besylate Generic | 471 | 939 | 96 | $2,963 |
| Diclofenac Epolamine Generic | 429 | 453 | 90 | $313K |
| Omeprazole Generic | 406 | 496 | 98 | $3,586 |
| Metformin Hcl Generic | 398 | 772 | 77 | $2,505 |
| Meloxicam Generic | 375 | 392 | 135 | $1,232 |
| Tamsulosin Hcl Generic | 340 | 659 | 72 | $2,877 |
| Metformin Hcl Er Metformin Hcl | 305 | 603 | 63 | $1,197 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 286 | 612 | 107 | $210 |
| Meclizine Hcl Generic | 281 | 311 | 84 | $3,909 |
| Esomeprazole Magnesium Generic | 270 | 333 | 69 | $3,672 |
Brand drugs: 2,863 claims; generic drugs: 11,882 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bo Chen $3,231 ($3,231 in general payments such as food, travel and fees) from 16 companies. The largest payer was Gilead Sciences, Inc. with $1,249.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 27 | $1,249 |
| Amgen Inc. AMGN | 7 | $495 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $370 |
| Kowa Pharmaceuticals America, Inc. | 6 | $202 |
| Exact Sciences Corporation EXAS | 8 | $183 |
| Madrigal Pharmaceuticals MDGL | 2 | $171 |
| Lilly USA, LLC LLY | 5 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $82.43 |
| Aimmune Therapeutics, Inc. | 4 | $75.73 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $63.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.